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Abstract: Apical periodontitis is an inflammatory reaction at the apex of an infected tooth.
Its microbiota resembles that of marginal periodontitis and may induce local and systemic antibodies
binding to bacteria- and host-derived epitopes. Our aim was to investigate the features of the
adaptive immune response in apical periodontitis. The present Parogene cohort (n = 453) comprises
patients with cardiac symptoms. Clinical and radiographic oral examination was performed to
diagnose apical and marginal periodontitis. A three-category endodontic lesion score was designed.
Antibodies binding to the bacteria- and host-derived epitopes were determined from saliva and serum,
and bacterial compositions were examined from saliva and subgingival samples. The significant ORs
(95% CI) for the highest endodontic scores were observed for saliva IgA and IgG to bacterial antigens
(2.90 (1.01–8.33) and 4.91 (2.48–9.71)/log10 unit), saliva cross-reacting IgG (2.10 (1.48–2.97)), serum IgG
to bacterial antigens (4.66 (1.22–10.1)), and Gram-negative subgingival species (1.98 (1.16–3.37)). In a
subgroup without marginal periodontitis, only saliva IgG against bacterial antigens associated with
untreated apical periodontitis (4.77 (1.05–21.7)). Apical periodontitis associates with versatile adaptive
immune responses against both bacterial- and host-derived epitopes independently of marginal
periodontitis. Saliva immunoglobulins could be useful biomarkers of oral infections including apical
periodontitis—a putative risk factor for systemic diseases.
Keywords: apical periodontitis; adaptive immunity; saliva; serum; antibody
1. Introduction
Apical periodontitis (AP) is an inflammatory disease that affects the tissues surrounding the
apex of the tooth. It is triggered by oral pathogens infecting root canal. Both acute (abscess) and
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chronic inflammatory reaction (periapical granuloma and radicular cyst) can develop depending on the
intensity of the bacterial infection and the host immune responses. Primary apical periodontitis usually
develops when the bacteria in a caries lesion enter through enamel and dentin and cause microbial
colonization of the pulp and eventually necrosis of the pulp tissue. Secondary apical periodontitis
arises from a persistent infection of previously treated root canals or leakage of the filling in a root
canal-treated tooth. Apical periodontitis is diagnosed from radiographs as an evident radiolucent area
(referred to as endodontic lesion) at the tip of the root. Even slight radiographically evident widening
of the periapical space is associated with an infection in the tooth [1]. AP is treated with root canal
treatment where infection is eliminated chemomechanically and the root canal is filled.
Apical periodontitis is a highly common and underdiagnosed disease. It is estimated that
approximately 10% of all teeth are endodontically treated, 5% have periapical radiolucencies [2],
and the prevalence of apical periodontitis varies between 24 and 86% in different populations [3]. Up to
78% of endodontically treated teeth have root canal fillings with poor quality and ~36% of the root
canal-treated teeth present apical periodontitis [2], suggesting that recurrent or persistent endodontic
infections are common. Apical periodontitis is usually symptomless, and it can be diagnosed only
by radiography.
Endodontic infections are polymicrobial and the structure of the intracanal biofilm may evolve
toward obligate aerobes and Gram-negative anaerobes as the infection progresses. More than
400 different microbial taxa have been identified in endodontic samples from teeth with different forms
of apical periodontitis [4]. Several studies have also shown that distinct bacterial communities are
found in primary and secondary AP [5–8]. Despite the high interindividual variability in endodontic
microbial community composition, the most often encountered phyla in the intracanal samples include
Firmicutes, Actinobacteria, Bacteroidetes, Proteobacteria, and Fusobacteria. Genera such as Prevotella,
Fusobacterium, Parvimonas, Lactobacillus, Streptococcus, and Porphyromonas are highly prevalent in
intracanal samples [9]. Several members of these genera are also considered etiological pathogens for
marginal periodontitis and the microbial profiles of these two conditions resemble each other [10].
Microbial antigens stimulate innate immune responses in periapical tissue aiming to restrict the
infection. The expression of proinflammatory cytokines, prostaglandins, and proteolytic enzymes
are markedly increased in the areas of tissue destruction [11]. As one antimicrobial strategy, apical
periodontitis is also associated with oxidative stress [12]. Some studies suggest a modest contribution
of endodontic infections to the plasmatic inflammatory markers [13,14], while a recent study found
a significant association between endodontic lesions and systemic inflammatory burden in young
adults [15].
Additionally, adaptive immune responses are activated to prevent the microbial invasion into the
tissues surrounding teeth or into circulation. High concentrations of local immunoglobulins IgG and
IgA and lesser amounts of IgM and secretory IgA are present in the inflamed tissues [16–19]. The levels
of systemic immunoglobulins, including total IgA, IgG, and IgM, are increased in patients with AP [13].
We recently showed that subgingival Porphyromonas endodontalis levels and serum IgG against it were
associated with a higher endodontic lesion score [20]. Several oral pathogens are also known to be able
to induce cross-reactive antibodies, which may influence inflammatory responses. The cross-reactive
antibodies are part of an immunological process called molecular mimicry, in which bacterial antigens
sufficiently resembling human proteins are able to induce the production of antibodies reacting with
human epitopes. The most studied epitopes include those present in the heat shock proteins (HSPs)
and in oxidized low-density lipoproteins (oxLDL) [21].
The association of marginal periodontitis with several systemic conditions such as cardiovascular
diseases (CVDs) is well established [22]. Due to similarities in the inflammatory and microbial profiles
between marginal periodontitis and AP, it is also suggested that there could be a link between AP and
CVDs [23,24]. Even though the possible association of apical periodontitis with systemic diseases has
been of high interest, the adaptive immune response against the disease has not been investigated in
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detail. In this study we aimed to investigate serum and saliva antibodies against several oral pathogens
associated with apical periodontitis and the role of cross-reactive antibodies in the disease.
2. Experimental Section
2.1. Population
The Corogene is a prospective cohort of Finnish patients who had an indication to coronary
angiography between June 2006 and March 2008 at the Helsinki University Hospital [25]. The present
study comprises the Parogene, which is a substudy of 508 patients with clinical and radiographic
oral health examinations. The details of the examinations have been described elsewhere [26].
The information of smoking habits was collected with a questionnaire before the oral examination.
The presence of diabetes (type I and II) was obtained from medical records. All subjects signed an
informed consent and the study was approved by the Helsinki University Hospital ethics committee
(approval reference number 106/2007). Patients with antibody measurements from serum and saliva
samples were included (n = 453, 89.2% of the whole cohort). The number of dentate patients and
subgingival samples was 426 (n of edentulous 27, 6.0%).
2.2. Oral Diagnosis
Endodontic lesions were diagnosed from the radiographs as described in detail earlier [20].
The recorded findings included root canal fillings, widened periapical space indicating irreversible
pulpitis or precursors for endodontic lesions [1], and apical periodontitis seen as periradicular
destruction in the tip of the root. An endodontic lesion score was defined to describe the severity of
apical periodontitis [20]. Score I included patients without endodontic lesions (n = 162, 38.2%); score II,
patients with ≥1 widened periapical space and/or 1 tooth with apical periodontitis (n = 194, 45.2%);
and score III, patients with ≥2 teeth with apical periodontitis (n = 68, 16.0%). In addition, another
subgrouping—the endodontic treatment score—was designed according to treated/untreated apical
periodontitis: I, no endodontic lesions (n = 352, 77.7%); II, teeth with apical periodontitis, all with
root canal fillings (n = 51, 11.3%); and III, apical periodontitis in tooth/teeth without root canal fillings
(n = 50, 11.0%). Number of teeth and implants, presence of carious teeth, and inadequate root canal
fillings were also recorded from the radiographs.
Diagnosis for marginal periodontitis was based on alveolar bone loss (ABL) detected in the
radiographs and bleeding on probing (BOP) registered in the clinical examination from four sites of
each tooth. Patient was considered periodontally healthy, when no ABL and <25% BOP was present;
with gingivitis, when no ABL but ≥25% BOP; and with periodontitis, when ABL was present [27].
2.3. Bacterial Analyses
Subgingival plaque samples were collected from the deepest pathological periodontal pocket
(≥ 4 mm) in each dentate quadrant as described earlier [28]. The microbiome analysis including 79
taxa was performed by using the checkerboard DNA-DNA hybridization assay [29] and the data was
analyzed as described in our earlier article [28]. In the present work, we summed up the results of
Gram-positive taxa (n = 45) and Gram-negative taxa (n = 34), which are presented in Supplementary
Table S1.
Saliva samples were collected after stimulation by chewing for 5 min, and a minimum of 2 mL of
saliva was collected by expectoration. The methods for sample processing and quantitative real-time
PCR have been described in detail earlier [30]. Saliva concentration of four bacterial species associated
with periodontitis was analyzed: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis,
Tannerella forsythia, and Prevotella intermedia.
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2.4. Antibody Determinations
Serum IgA- and IgG-class antibody levels against seven bacterial species—A. actinomycetemcomitans,
P. gingivalis, T. forsythia, P. intermedia, Campylobacter rectus, Fusobacterium nucleatum,
and P. endodontalis—were determined with ELISA as described earlier [31]. The antigens were
composed of formalin-killed whole cells and two dilutions in duplicate were measured [32]. After all
antibody levels were determined, the absorbances were normalized according to the reference applied
on each plate and the results were expressed as continuous ELISA-units (EU). The list of the antigens,
sample dilutions, and coefficients of interassay variations are presented earlier [31].
Saliva IgA- and IgG-class antibody levels against five species—A. actinomycetemcomitans,
P. gingivalis, T. forsythia, P. intermedia, and P. endodontalis—were determined from saliva supernatants
obtained after centrifugation at 9300× g for 3 min. The target antigens used in the assays were
either heat-killed whole bacterial cells or oxidized LDL epitope malondialdehyde acetaldehyde
modification (MAA-LDL), copper-oxidized LDL (CuOx-LDL) [33], recombinant P. gingivalis virulence
factor gingipain (Rgp44) [34], and 60-kDa A. actinomycetemcomitans heat shock protein (Aa-HSP60) [35].
Levels of salivary IgA and IgG antibodies to oxidized LDL and bacterial epitopes were determined by
chemiluminescence immunoassay as previously described in detail [36,37]. The saliva samples were
diluted accordingly: 1:250 for total IgA and IgG, 1:50 for IgA to oxidized antigens, 1:20 for Aa-HSP60,
and 1:10 for bacterial antigens. For IgG measurements, saliva samples were diluted 1:10 for all antigens.
Each saliva sample was measured as triplicates. Immunoassay results were presented as relative light
units (RLU) per 100 milliseconds (ms).
2.5. Calculations of Cross-Reactive Antibodies and Antibodies Binding to Bacterial Antigens
In addition to the mean levels of antibodies against each specific antigen, the combined
antibody levels of saliva and serum IgA and IgG were calculated. The bacterial antigens included
A. actinomycetemcomitans, P. gingivalis, P. intermedia, P. endodontalis, and T. forsythia (referred as
IgA/IgG against bacteria). The epitopes recognized in P. gingivalis and A. actinomycetemcomitans
giving rise to cross-reactive antibodies with MAA-LDL included Rgp-44 and Aa-HSP60 (referred as
cross-reacting IgA/IgG).
2.6. Statistical Methods
The characteristics are presented as mean values with standard deviations (SD) or 95%
confidence intervals. For clarity, standard error is displayed in the figures as error bars. In the
supplementary tables, the bacterial levels are presented as medians and interquartile ranges (IQR).
Before statistical comparisons, the antibody and bacterial levels were transformed with 10-base
logarithm. The significance of the differences was tested by using t-test, ANOVA, Chi-square,
or Mann–Whitney, when appropriate. The weighted linear terms were examined with ANOVA and
Jonckheere–Terpstra test for normally distributed and skewed data, respectively. The associations were
analyzed by using linear and logistic regression models adjusted for age, sex, marginal periodontitis
(healthy, gingivitis, and periodontitis), number of teeth, and smoking (never/ever). When the dependent
variable was composed of several subgroups, multinomial regression was used. When the associations
were examined in the subgroup of patients without marginal periodontitis, the confounders were
limited to age, sex, and smoking (never/ever).
3. Results
Characteristics of the dentate population are presented in Table 1. The mean (SD) age was 62.9 (9.1)
years and 67% were males. The mean number of teeth was 21.4 (7.5), and caries and apical periodontitis
were common findings, in 47.4% and 23.8% of the population, respectively. Also, marginal periodontitis
ranging from mild to severe was present in most patients (75.5%).
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Table 1. Characteristics of the population.
Character Mean (SD)
Age (years) 62.9 (9.1)
BMI (kg/m2) 27.8 (5.1)
Number of teeth 21.4 (7.5)
Mean (95% CI)
Number of implants 0.12 (0.05–0.18)
Carious teeth 0.99 (0.84–1.14)
Root canal fillings 2.17 (1.96–2.39)
Inadequate root fillings 1.08 (0.95–1.20)
Widened periapical space 0.80 (0.71–0.89)
Apical periodontitis 0.36 (0.27–0.45)
With root canal fillings
Without root canal fillings
0.16 (0.12–0.21)
0.19 (0.11–0.27)
N (%)
Gender (males) 284 (67.0)
Smoking (ever) 220 (51.9)
Hypertension 266 (62.9)
Diabetes (type I or II) 92 (21.9)
Dyslipidemia 340 (80.6)
Carious teeth 198 (47.4)
Root canal fillings 304 (71.7)
Widened periapical spaces 224 (53.8)
Apical periodontitis 101 (23.8)
Endodontic lesion score No endodontic lesions 162 (38.2)
≥1 tooth with widened periapical space or one tooth with
apical periodontitis 194 (45.8)
≥2 teeth with apical periodontitis 68 (16.0)
Endodontic treatment score No endodontic lesions 323 (76.2)
Apical periodontitis in teeth with root canal fillings 51 (12.0)
Apical periodontitis in teeth without root canal fillings 50 (11.8)
Marginal periodontitis Healthy 42 (9.9)
Gingivitis 61 (14.4)
Periodontitis 320 (75.5)
The endodontic findings registered included root canal fillings, widened periapical space, and
apical periodontitis. Mean antibody levels in serum and saliva against specific antigens, as well
as the saliva and subgingival bacterial levels according to the endodontic findings are presented in
supplementary tables (Supplementary Tables S2 and S3).
Among serum or saliva IgA-class antibody levels only sporadic significant differences were
observed between patients with and without endodontic findings, whereas among IgG-class antibodies
several significant differences were found. The antigens producing these differences included
A. actinomycetemcomitans, P. gingivalis, P. intermedia, P. endodontalis, C. rectus, F. nucleatum, and T. forsythia,
as well as Aa-HSP60, rgp44, MAA-LDL, and CuOx-LDL (Table S2). Among the salivary or subgingival
bacterial concentrations, significant differences were mostly found between patients with and without
widened periapical spaces (Table S3).
For further analyses, the microbial biomarkers were combined, and the mean levels are presented
in Figures 1 and 2. The combinations included antibody level against bacteria, cross-reactive antibodies,
salivary bacteria, and subgingival bacteria. Similarly as above, the mean saliva IgG-class antibody
levels against bacteria and the cross-reactive antibodies as well as saliva and subgingival bacterial
levels were higher in patients with endodontic findings. From the serum antibody levels, the IgG
against bacteria were higher only in patients with widened periapical spaces (p = 0.015). In these
patients, the increase of subgingival bacterial levels was due to both Gram-positive (p = 0.022) and
Gram-negative (p = 0.005) species.
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and T. forsythia were determined by qPCR, and subgingival A. actinomycetemcomitans, P. gingivalis, P. 
intermedia, P. endodontalis, and T. forsythia by checkerboard DNA–DNA hybridization (A). This 
method was also used to examine subgingival 79 taxa, which were divided into Gram-positive (n = 
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The associations of antibody and bacterial levels with endodontic findings are presented in Table 
2 for the whole population calculated by using linear and logistic regression models adjusted for age, 
sex, number of teeth, smoking, and status of marginal periodontitis. The estimates are presented for 
a 10-fold increase in the antibody or bacterial levels, number of root canal-treated teeth associated 
with saliva IgA and IgG against bacteria, and cross-reacting IgG. Among these, only saliva IgG 
against bacteria associated with the presence of root canal-treated teeth with an OR (95% CI) 2.52 
Figure 1. Saliva and serum antibody levels according to endodontic findings. The patients were
divided into groups according to the presence of root canal fillings, widened periapical spaces, and
apical periodontitis. Saliva (A, B) and serum (C) IgA- and IgG-class antibodies were determined.
The bacterial antigens included A. actinomycetemcomitans, P. gingivalis, P. intermedia, P. endodontalis,
and T. forsythia. The antigens giving rise to cross-reactive antibodies included MAA-LDL, Rgp-44,
and Aa-HSP60. White columns depict the absence of the endodontic finding and black columns
depict the presence of the endodontic finding. Means and standard errors are shown. The asterisks
depict statistical significance between the groups defined by the t-test after logarithmic transformation:
* p < 0.05, ** p < 0.01. *** p < 0.001.
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Figure 2. Saliva and subgingival bacteria according to endodontic findings. The patients were divided
into groups according to the presenc of root ca al fillings, widene periapical spaces, and ap cal
peri dontiti . Salivary bacterial concentrations of A. act nomycetemcomitans, P. gingivalis, P. intermedia,
and T. f rsy hia were determined by qPCR, and subgingival A. actin ycetemcomitans, P. gingivalis, P.
intermedia, P. endodontalis, and T. fors thia by checker oard DN –DNA h bridization (A). This method
was also used to examine ubgingival 79 taxa, which were divided into Gram-positive (n = 45) and
Gram-negative (n = 34) (B). The white columns depict the absence, and black columns presence of the
endodontic findi g. Means and standard errors ar shown. The asterisks depict statistica significance
betw en the groups defi ed by the t-test after logarithmic transformation: * p < 0.05, ** p < 0.01.
*** p < 0.001.
The associations of antibody and bacterial levels with endodontic findings are presented in Table 2
for the whole population calculated by using linear and logistic regression models adjusted for age,
sex, number of teeth, smoking, and status of marginal periodontitis. The estimates are presented for a
10-fold increase in the antibody or bacterial levels, number of root canal-treated teeth associated with
saliva IgA and IgG against bacteria, and cross-reacting IgG. Among these, only saliva IgG against
bacteria associated with the presence of root canal-treated teeth with an OR (95% CI) 2.52 (1.43–4.43).
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Number of widened periapical spaces associated with saliva cross-reactive IgA and IgG, saliva IgG
against bacteria, and subgingival bacteria in linear regression models. The presence of widened
periapical spaces associated with saliva IgA and IgG against bacteria with ORs 2.09 (1.01–4.34) and
2.25 (1.40–3.61), respectively, and with cross-reacting IgG, 1.56 (1.22–1.99). Significant associations were
also observed between the presence of widened periapical space and Gram-positive and Gram-negative
subgingival bacteria with ORs 1.40 (1.02–1.92) and 1.45 (1.05–2.00). Number of teeth with apical
periodontitis associated with saliva IgG against bacteria and cross-reacting IgG, which also presented
significant ORs with the presence of apical periodontitis (2.90 (1.71–4.92) and 1.62 (1.24–2.11)).
A 3-category endodontic lesion score was designed for the severity of apical periodontitis.
In addition, a 3-category endodontic treatment score was designed to investigate the contribution of
treatment (root canal fillings) on the associations. The characteristics of the population are presented
according to these scores in Table 3. Number of teeth, carious teeth, teeth with root canal fillings, and
inadequate root canal fillings increased significantly with increasing scores. Also marginal periodontitis
was more prevalent with high endodontic lesion (p < 0.001) or endodontic treatment (p = 0.287) score.
Mean antibody levels in serum and saliva against specific antigens, as well as the saliva and subgingival
bacterial levels according to these scores are presented in supplementary tables (Table S4 and S5).
The association of the scores with the combined microbial biomarkers was analyzed by multinomial
regression models for the log10-transforemed units (Figure 3). All measured parameters displayed
positive trends with the increasing endodontic lesion score. Statistically significant associations (OR
(95% CI)) with the highest endodontic scores were observed for saliva IgA (2.90 (1.01–8.33)) and
IgG (4.91 (2.48–9.71)) against bacteria, saliva cross-reacting IgG (2.10 (1.48–2.97)), serum IgG against
bacteria (4.66 (1.22–10.1)), subgingival species (1.15 (1.07–1.25)), and Gram-negative subgingival
species (1.98 (1.16–3.37)). Regarding the treatment, only saliva IgG against bacteria, cross-reacting IgG,
and serum IgA and IgG displayed increasing trends. Significant odds (OR (95%CI)) for untreated apical
periodontitis were observed for saliva IgG against bacteria (5.32 (2.61–10.8)) and for cross-reacting IgG
(2.04 (1.44–2.88)) (Figure 3).
The main results were reanalyzed in the subgroup of patients without marginal periodontitis
(n = 132). There were no significant differences in the bacterial levels between groups divided
according to the endodontic findings. Saliva IgG antibodies against bacteria and cross-reacting
antibodies were higher in subjects with root canal fillings (p = 0.003 and 0.004), widened periapical
spaces (p = 0.008 and 0.008), and apical periodontitis (p = 0.012 and 0.385). Both antibody levels
increased in groups of patients with increasing endodontic scores (p for linear trend 0.009 and 0.020).
The antibodies against bacteria (p for linear trend 0.007), but not the cross-reacting antibodies (p = 0.569),
increased in patients with greater endodontic treatment scores. The associations of the saliva IgG
class antibodies with endodontic lesion score and endodontic treatment score are presented in Table 4.
Increasing trends were observed clearly only for saliva IgG against bacteria; the multivariate odds (OR
(95% CI)) for having multiple teeth with apical periodontitis and for having teeth with untreated apical
periodontitis were 3.45 (0.83–14.3) and 4.77 (1.05–21.7), respectively.
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Table 2. Associations of endodontic findings with saliva and serum antibody levels and bacterial concentrations.
Root Canal Fillings Widened Periapical Space Apical Periodontitis
Beta, p-Value OR (95% CI), p Beta, p-Value OR (95% CI), p Beta, p-Value OR (95% CI), p
Saliva IgA against bacteria * 0.096, 0.041 2.162 (0.934–5.004), 0.072 0.062, 0.204 2.090 (1.007–4.337), 0.048 0.059, 0.235 1.995 (0.870–4.573), 0.103
Saliva IgG against bacteria * 0.169, <0.001 2.519 (1.431–4.434), 0.001 0.138, 0.005 2.246 (1.397–3.611), 0.001 0.182, <0.001 2.904 (1.714–4.922), <0.001
Serum IgA against bacteria * 0.031, 0.527 1.144 (0.516–2.539), 0.741 0.017, 0.738 1.513 (0.753–3.040), 0.245 0.037, 0.476 0.922 (0.421–2.018), 0.838
Serum IgG against bacteria * 0.010, 0.838 1.272 (0.443–3.656), 0.655 0.002, 0.963 2.048 (0.840–4.995), 0.115 0.083, 0.102 1.710 (0.615–4.754), 0.304
Saliva pathogen sum 0.012, 0.802 0.996 (0.932–1.064), 0.900 0.068, 0.163 1.046 (0.989–1.107), 0.117 0.079, 0.111 0.998 (0.936–1.064), 0.951
Subgingival pathogen sum 0.053, 0.273 0.991 (0.934–1.051), 0.760 0.086, 0.085 1.051 (0.999–1.105), 0.056 0.098, 0.049 1.047 (0.987–1.112), 0.127
45 gram-positive taxa 0.025, 0.603 0.754 (0.515–1.104), 0.147 0.121, 0.014 1.395 (1.016–1.917), 0.040 0.045, 0.375 1.096 (0.761–1.578), 0.622
33 gram-negative taxa 0.056, 0.237 0.945 (0.660–1.353), 0.757 0.121, 0.014 1.446 (1.046–1.999), 0.026 0.059, 0.238 1.249 (0.850–1.836), 0.257
Saliva cross-reactive IgA ** 0.086, 0.067 1.248 (0.926–1.680), 0.146 0.096, 0.049 1.295 (0.995–1.685), 0.055 0.064, 0.196 1.327 (0.986–1.788), 0.062
Saliva cross-reactive IgG ** 0.128, 0.006 1.240 (0.942–1.632), 0.125 0.160, 0.001 1.555 (1.217–1.987), <0.001 0.159, 0.001 1.615 (1.237–2.108), <0.001
The dependent variable in the linear regression was the number of findings and in the logistic regression the presence of findings. Adjusted for age, sex, marginal periodontitis
(healthy, gingivitis, periodontitis), number of teeth, and smoking (never/ever). * Antibodies against A. actinomycetemcomitans, P. gingivalis, P. intermedia, P. endodontalis, and T. forsythia;
** Cross-reactive antibodies, antigens Pg-Rgp44, Aa-HSP60, and MAA-LDL.
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Table 3. Characteristics of the population according to endodontic scores.
Character Endodontic Lesion Score Endodontic Treatment Score
Score I Score II Score III Score I Score II Score III
Mean (SD) P 1 Mean (SD) P 1
Age (years) 63.3 (9.2) 63.1 (8.7) 63.7 (9.8 0.924 63.3 (9.0) 64.3 (9.0) 62.5 (9.5) 0.578
BMI (kg/m2) 27.8 (5.0) 27.8 (5.1) 27.8 (4.4) 0.990 27.7 (5.0) 27.9 (4.8) 28.2 (4.8) 0.852
Number of teeth 18.1 (10.5) 21.5 (7.3) 22.0 (6.7) <0.001 19.7 (9.3) 23.2 (6.0) 20.5 (8.0) 0.031
Mean (95% CI) Mean (95% CI)
Number of implants 0.17 (0.04–0.29) 0.10 (0.01–0.20) 0.12 (0.04–0.28) 0.696 0.15 (0.06–0.23) 0.14 (0.07–0.35) 0.02 (0.02–0.06) 0.546
Carious teeth 0.68 (0.52–0.84) 0.97 (0.75–1.18) 1.74 (1.20–2.27) <0.001 0.83 (0.69–0.98) 1.24 (0.76–1.71) 1.82 (1.10–2.53) <0.001
Root canal fillings 0.95 (0.73–1.17) 2.54 (2.26–2.82) 3.91 (3.21–4.61) <0.001 1.82 (1.61–2.02) 4.65 (3.84–5.45) 1.91 (1.28–2.54) <0.001
Inadequate root fillings 0.41 (0.29–0.52) 1.26 (1.10–1.42) 2.07 (1.64–2.51) <0.001 0.88 (0.76–1.00) 2.33 (1.83–2.84) 1.05 (0.65–1.44) <0.001
N (%) P 2 N (%) P 2
N (%) 189 (41.7) 196 (43.3) 68 (15.0) 352 (77.7) 51 (11.3) 50 (11.0)
Sex (males) 123 (65.1) 132 (67.3) 47 (69.1) 0.803 234 (66.5) 33 (64.7) 35 (70.0) 0.842
Smoking (ever) 92 (48.9) 112 (57.1) 35 (51.5) 0.265 190 (54.1) 23 (45.1) 26 (52.0) 0.478
Hypertension 122 (64.6) 123 (63.4) 41 (61.2) 0.885 226 (64.6) 30 (58.8) 30 (61.2) 0.683
Diabetes (type I/II) 39 (20.9) 47 (24.2) 14 (21.2) 0.711 78 (22.4) 11 (22.0) 11 (22.4) 0.998
Dyslipidemia 148 (78.3) 165 (85.5) 49 (73.1) 0.050 285 (81.7) 42 (84.0) 35 (70.0) 0.121
Marginal periodontitis 111 (58.7) 154 (78.6) 56 (82.4) <0.001 244 (69.3) 37 (72.5) 40 (80.0) 0.287
1 ANOVA; 2 Chi-square test; Endodontic lesion score: score I, no endodontic lesions; score II, patients with ≥1 widened periapical space and/or 1 tooth with apical periodontitis; and score
III, patients with ≥2 teeth with apical periodontitis. Endodontic treatment score: score I, no endodontic lesions; score II, apical periodontitis only in teeth with root canal fillings; score III,
apical periodontitis in teeth without root canal fillings.
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Table 4. Association of saliva IgG class antibody levels with endodontic scores in the subpopulation free from marginal periodontitis.
OR (95% CI), P-Value
Saliva IgG Against Bacteria * Saliva Cross-Reacting IgG **
Univariate Multivariate 1 Univariate Multivariate 1
Endodontic lesion score
No endodontic lesions 1.0 1.0 1.0 1.0
≥1 tooth with widened periapical space or apical periodontitis 2.92 (1.17–7.26), 0.022 2.67 (1.03–6.94), 0.044 2.06 (1.31–3.22), 0.002 1.97 (1.24–3.11), 0.004
≥2 teeth with apical periodontitis 3.88 (0.99–15.5), 0.050 3.45 (0.83–14.3), 0.088 1.32 (0.65–2.69), 0.435 1.30 (0.64–2.62), 0.472
Endodontic treatment score
No endodontic lesions 1.0 1.0 1.0 1.0
Apical periodontitis in teeth with root canal fillings 2.52 (0.70–9.06), 0.157 2.44 (0.66–9.06), 0.184 1.11 (0.60–2.03), 0.746 1.12 (0.60–2.08), 0.731
Apical periodontitis in teeth without root canal fillings 5.88 (1.32–26.2), 0.020 4.77 (1.05–21.7), 0.043 1.43 (0.73–2.80), 0.297 1.39 (0.70–2.78), 0.351
1 Adjusted for age, sex, and smoking (never/ever). Multinomial logistic regression. * Antibodies against A. actinomycetemcomitans, P. gingivalis, P. intermedia, P. endodontalis, and T. forsythia;
** Cross-reactive antibodies, antigens Pg-Rgp44, Aa-HSP60, and MAA-LDL.
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Figure 3. Associations of the antibody and bacterial levels with endodontic lesion score and endodontic
treatment score. Endodontic lesion score (A): score I, no endodontic lesions; score II, patients with ≥1
widened periapical space and/or 1 tooth with apical periodontitis; and score III, patients with ≥2 teeth
with apical periodontitis. Endodontic treatment score (B): score I, no endodontic lesions; score II, apical
periodontitis only in teeth with root canal fillings; score III, apical periodontitis in teeth without root
canal fillings. The associations were investigated by using multinomial regression models adjusted
for age, sex, marginal periodontitis (healthy, gingivitis, periodontitis), number of teeth, and smoking
(never/ever). The estimates for lowest (reference), middle, and highest scores are depicted with white,
gray, and black diamonds, respectively.
4. Discussion
We showed that apical periodontitis is associated with elevated levels of saliva IgA and IgG and
serum IgG against bacterial antigens and saliva cross-reacting IgG, which recognise both bacterial
and host epitopes. The associations were independent of marginal periodontitis. The local antibody
response may contribute to the systemic IgG levels, which associate with the severity of apical
periodontitis and arise mainly from untreated apical infections. High salivary IgA was associated with
the number of widened periapical spaces, most likely indicating early endodontic infection.
Elevated levels of salivary total IgG associated with endodontic findings including root canal
treatments, widened periapical spaces and radiographically diagnosed apical periodontitis. Both
the presence and number of endodontic findings were significantly associated with total salivary
IgG levels. In the case of total salivary IgA, the presence of root canal fillings and the number of
widened periapical spaces, but neither the presence nor the number of teeth with apical periodontitis,
associated with higher antibody levels. In health, the saliva IgGs mainly derive from the circulation by
transudation through the gingival crevice. They comprise less than 15 percent of the total salivary
immunoglobulins, as the major salivary immunoglobulin is secretory IgA produced by the salivary
glands in mucosal plasma cells [38,39]. However, high concentrations of IgG and IgA and smaller
amounts of IgM and secretory IgA have been detected within the periapical granulomas, in periapical
cysts, as well as in root canal exudates with periapically affected teeth [40]. In addition, the total IgG
and IgA levels detected from the periapical exudate were shown to correlate with clinical findings of
the infected teeth [41]. As the half-life of IgA-class antibodies is only a few days, they are considered to
reflect either recent or repeated exposure to the pathogen, while IgG is more stable, thus indicating
a past, and maybe chronic, infection. Widened periapical spaces reflect either symptomatic teeth
with irreversible pulpitis or precursors for established AP in necrotic teeth [1]. Since all determined
antibody levels and bacterial concentrations correlated with the endodontic score, our results support
the suggestion that the widened periapical spaces are likely to reflect early endodontic lesions [20].
When antibody response was studied in more detail, it was observed that salivary IgG levels against
all studied species (A. actinomycetemcomitans, P. gingivalis, P. intermedia, P. endodontalis, and T. forsythia)
were significantly higher in the groups with endodontic findings. In addition, patients with widened
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periapical spaces had higher saliva IgA-antibodies against P. endodontalis. It is widely accepted that
endodontic infections have a multimicrobial etiology [4], and several pathogens associated with
marginal periodontitis, such as P. intermedia, P. gingivalis, T. denticola and P. endodontalis, are frequently
detected in teeth with necrotic pulps [42–44]. As apical periodontitis is often restricted to the periapical
tissues, it is not surprising that the amount of studied salivary and subgingival bacteria were not
consistently associated with the endodontic findings. On the other hand, it is reported that in the case
of combined endodontic-periodontal lesions, where apical periodontitis can be initiated either in the
pulp or in the periodontium, the microbial profiles of apical lesions and periodontal pockets resemble
each other [10]. In such cases, it is probable that bacteria enter the root canal from the periodontium
via the apical foramen, dentinal tubules and accessory root canals [45].
Two major pathogens in marginal periodontitis, A. actinomycetemcomitans and P. gingivalis,
express several virulence factors including P. gingivalis-specific gingipains degrading the extracellular
matrix and bioactive peptides [46], as well as heat shock proteins (HSPs) produced by both
species [47]. These proteins elicit strong antibody production and are also able to induce a variety
of cross-reactive antibodies recognizing human epitopes such as HSPs and oxidized low-density
lipoproteins (oxLDL). These cross-reactions are considered potential links between periodontitis and an
increased risk of cardiovascular diseases [21]. The oxidation of LDL gives rise to various epitopes and
a frequently used model of oxLDL include the immunodominant epitopes malondialdehyde (MDA)
and malondialdehyde acetaldehyde (MAA). It is reported that the presence of antibodies binding
to MDA-LDL is associated with both the progression of atherosclerosis and with the presence and
severity of periodontitis [37,48–50]. A monoclonal IgM antibody to MDA-LDL recognizes P. gingivalis
virulence factor gingipain (Rgp44) as an antigen [34] and A. actinomycetemcomitans heat shock protein
60 (Aa-HSP60) cross-reacts with MAA-LDL [35]. To our knowledge, this study is the first to show the
association between apical periodontitis and salivary cross-reactive antibodies. Especially cross-reactive
antibodies representing IgG-class were strongly associated with different endodontic conditions.
All measured parameters displayed positive trends with increasing number of endodontic findings
as both the salivary IgA and IgG against bacterial antigens, as well as the cross-reacting IgG, were
significantly associated with the highest endodontic score. In addition, the effect of endodontic
treatment on antibody response was evident indicating that the levels of both saliva IgG against
bacterial antigens and cross-reacting IgG were significantly higher in the patients with primary apical
periodontitis compared to those who had apical periodontitis in teeth with root canal fillings. The aim
of root canal treatment is to eradicate the biofilm from the infected root canal and prevent the recurrent
infection. However, if the treatment is inadequately performed, some bacteria may survive and cause
secondary infection. The microbiome of endodontically treated root canals consists of fewer bacterial
species, and some of the species are more resilient to endodontic treatment [10]. This phenomenon
may reflect to the levels of antibodies measured in this study.
The production of local IgGs is also enhanced in advanced marginal periodontitis by local plasma
cells of the gingiva [51]. We repeated our main analyses in a subgroup of subjects without marginal
periodontitis. Although the number of patients in this subgroup was low, the association between
saliva IgG against bacterial antigens and primary apical periodontitis remained significant, suggesting
further that IgG antibody response is independent of marginal periodontitis.
The main limitation of this study is that our study population consists of middle-aged and elderly
participants, and thus the oral infections are very common. In addition, all participants had an initial
indication for coronary angiography. Another restriction is the lack of intracanal bacterial samples;
hence the bacterial analyses were only conducted from saliva and subgingival samples. Different
methods were used for the detection of the antibody levels in serum and saliva, and not the same
antibody panels were available. For instance, we did not have information on the serum cross-reactive
antibodies, which will be an aim for future investigations. Also different methodologies were used
for the bacterial analyses, since the subgingival samples were examined by checkerboard DNA–DNA
hybridization and the saliva samples by qPCR.
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Although apical periodontitis has been considered as a potential risk factor for systemic diseases
such as coronary artery disease (CAD) [52], only a few studies have attempted to draw conclusions
on the associations between apical periodontitis and systemic diseases. Evidence for the association
between AP and CVDs, such as endothelial dysfunction [53], atherosclerosis [54], and coronary heart
disease [55], has been reported in separate studies. However, recent systematic reviews suggest only
modest participation of endodontic infection on the systemic levels of biomarkers and a moderate or
low correlation between some systemic diseases and apical periodontitis [14,23,24,56]. In our recent
study, we demonstrated a confounder-adjusted association between apical periodontitis and CAD [20].
In the present study, we showed that apical periodontitis may contribute to the levels of IgG in serum
which link oral bacteria to CAD risk [31]. These serum antibodies have been repeatedly associated
with prevalent and incident CVD as well as with subclinical atherosclerosis [57–60]. Also the saliva
cross-reacting antibodies and immunoglobulins against bacterial antigens have been associated with
increased risk for CAD [37].
Salivary immunoglobulins are potential biomarkers of oral infectious diseases, but the specific
antigens should be selected carefully. This would be especially beneficial in the case of apical
periodontitis, as the disease is often asymptomatic and remains undiagnosed. This study represents a
limited set of antibodies against selected bacterial targets, and further research is needed to investigate
the levels of antibodies against other bacterial species commonly found in infected root canals.
5. Conclusions
Our results suggest that the inflammatory condition caused by endodontic infections could be
identified by the increased salivary IgG levels independently of marginal periodontitis. The levels of
saliva IgG may have a small, but significant effect on the systemic levels of biomarkers, indicating the
potential link between apical periodontitis and systemic diseases.
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